EW Stock Quote
Company Report
Edwards Lifesciences Corporation is a global leader in providing advanced medical technologies focused on structural heart disease, critical care, and surgical monitoring. Operating across the United States, Europe, Japan, and other international markets, the company specializes in innovative solutions that enhance patient outcomes through minimally invasive procedures. Its flagship products include transcatheter heart valve replacement systems designed for the less invasive treatment of heart valve conditions, alongside transcatheter valve repair solutions for mitral and tricuspid valve diseases.
In addition to its transcatheter offerings, Edwards Lifesciences offers surgical structural heart solutions under brands like INSPIRIS and KONECT RESILIA. These include aortic surgical valves and tissue valved conduits designed for patients requiring comprehensive valve and aortic root replacements. The company also pioneers technologies such as the HARPOON Beating Heart Mitral Valve Repair System, aimed at addressing degenerative mitral regurgitation through innovative surgical approaches.
Complementing its structural heart portfolio, Edwards Lifesciences provides critical care solutions including advanced hemodynamic monitoring systems. These systems play a crucial role in measuring heart function and fluid status in surgical and intensive care environments. With a commitment to innovation and patient-centric care, Edwards Lifesciences continues to advance medical technologies that improve the quality of life for patients worldwide from its headquarters in Irvine, California, where it was founded in 1958.
EW EPS Chart
EW Revenue Chart